Search Results - "Burke-Conte Z"

Influence of Anti-VEGF Injections on Longitudinal Changes in Vascular Metrics Measured by OCTA in Age Related Macular Degeneration: A Retrospective Real-World Study.

Authors: Zhu, Ying Gumustop, Selin S Wang, Leiyu et al.

Source: Clinical Ophthalmology. May2026, Vol. 20, p1-8. 8p.

Explainable AI for glaucoma detection and classification: a comprehensive review.

Authors: Abd El-Gawad, Ahmed M. Hassan, Sarah Elsharkawy, Mohamed et al.

Source: Artificial Intelligence Review; Jul2026, Vol. 59 Issue 7, p1-59, 59p

"You never know what's in front of you": A mixed methods study of barriers and facilitators to physical activity among blind and low-vision adults with type 2 diabetes.

Authors: Nicklett, Emily J. Stensland, Meredith L. Qin, Weidi et al.

Source: PLoS ONE. 6/17/2026, Vol. 21 Issue 6, p1-29. 29p.

Interpreting Services Bridge Language Gaps in Diabetic Retinopathy Care: A Retrospective Cohort Study.

Authors: Boyle, Robert Sy, Kaitlyn Abigail Krachmalnick, Sara et al.

Source: Clinical Ophthalmology. Apr2026, Vol. 20, p1-10. 10p.

Impact of Prior Diabetic Retinal Screening on Hospitalization and Ophthalmic Follow-Up in Diabetic Patients with Newly Diagnosed Proliferative Diabetic Retinopathy.

Authors: Zhang, Charles Sonik, Neel R. Tsoukas, Zoe J. et al.

Source: Diagnostics (2075-4418). May2026, Vol. 16 Issue 10, p1562. 12p.

Efficacy of Netarsudil in Open and Closed Angle Glaucomas Within the Vietnamese Population: A Single-Center, Retrospective Study.

Authors: Truong, Dzuy Nguyen, Kelly C Chansangpetch, Sunee et al.

Source: Clinical Ophthalmology. May2026, Vol. 20, p1-9. 9p.

Association of Behavioral Factors with Activation in Patients with Age-Related Macular Degeneration or Diabetic Retinopathy.

Authors: Morse, Alan R Hark, Lisa A Seiple, William H et al.

Source: Clinical Ophthalmology. Aug2025, Vol. 19, p3059-3069. 11p.

Expanding Access to Retinal Imaging Through Patient-Operated Optical Coherence Tomography in a Veterans Affairs Retina Clinic.

Authors: Dogan, Alan B. Barber, Katherine G. Devine, Brigid C. et al.

Source: Bioengineering (Basel). Jan2026, Vol. 13 Issue 1, p61. 15p.

Resilience to Diabetic Retinopathy (RDR) Is Associated with a Pre-Retinopathy Transcriptional Program Induced by Diabetes.

Authors: Rajasekar, Janani Zappia, Maria Paula McCann, Maximilian A. et al.

Source: Biomolecules (2218-273X). Apr2026, Vol. 16 Issue 4, p614. 16p.

Omega-3 Fatty Acid Supplementation and Incident Age-Related Macular Degeneration in a United States Veteran Population: A Retrospective Cohort Study.

Authors: Cao, Angela A. Westanmo, Anders D. Gravely, Amy A. et al.

Source: Journal of Clinical & Translational Ophthalmology. Mar2026, Vol. 4 Issue 1, p7. 10p.

The Burden of Delayed Diabetic Retinopathy Management and Use of Artificial Intelligence-Driven Screening Tools: A Systematic Literature Review.

Authors: Rahhal, Firas Zhang, Jun Mukherjee, Munia

Source: Ophthalmology & Therapy. Mar2026, Vol. 15 Issue 3, p925-943. 19p.

Trends in First-Line Glaucoma Treatment from 2013 to 2024: A Multi-institutional and Multinational Cohort Study.

Authors: Chuang, Lan-Hsin Tsai, Daniel Hsiang-Te Chan, Yuan-Hsi et al.

Source: Ophthalmology & Therapy. Mar2026, Vol. 15 Issue 3, p1083-1094. 12p.

Mapping disparities in diabetic eye exam adherence using geographic information systems.

Authors: Dogra, Neil Sai Geiss, Michael Patrick Gearinger, Talia et al.

Source: PLoS ONE. 2/13/2026, Vol. 21 Issue 2, p1-12. 12p.

Cross-Sectional Survey of Real-World Physician Prescribing Practices for Anti-VEGF Agents in the Treatment of Neovascular Age-Related Macular Degeneration and Associated Patient Burden in the United States.

Authors: Gulati, Shilpa Coak, Emily Mascia, Daniel et al.

Source: Clinical Ophthalmology. Feb2026, Vol. 20, p1-16. 16p.

A Systematic Review and Meta-Analysis Assessing Diversity and Representation in Diabetic Retinopathy Clinical Trials in the U.S.

Authors: Elghzali, Ahmed Swami, Vinay Hossain, M. D. et al.

Source: Ophthalmic Epidemiology. Oct2025, Vol. 32 Issue 5, p465-475. 11p.

Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.

Authors: Baljoon, Ahmead Diaby, Vakaramoko Suther, Sandra et al.

Source: PharmacoEconomics - Open. May2026, Vol. 10 Issue 3, p457-469. 13p.

Balancing Pressure and Pills: Short-Term Outcomes of Goniotomy vs. Trabeculectomy in Adult Glaucoma.

Authors: Kahlon, Sunny Jarstad, John Steven

Source: Journal of Clinical & Translational Ophthalmology. Dec2025, Vol. 3 Issue 4, p27. 10p.

Revolutionizing Diabetic Retinopathy Screening: Integrating AI-Based Retinal Imaging in Primary Care.

Authors: Beals, Dean Simon, Lesley Rogers, Faith et al.

Source: Journal of CME. Dec2025, Vol. 14 Issue 1, p1-7. 7p.

Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials.

Authors: Friedman, Scott M. Xu, Yingxin Sherman, Steven et al.

Source: Ophthalmology & Therapy. Nov2025, Vol. 14 Issue 11, p2919-2936. 18p.

Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.

Authors: Kuznik, Andreas Coughlan, Anna Pinsent, Amy et al.

Source: Ophthalmology & Therapy. Nov2025, Vol. 14 Issue 11, p2863-2875. 13p.